| Literature DB >> 35422735 |
Kubra S Sajid1, Shahbaz Hussain1,2, Rai I Hussain1, Bakhtawar Mustafa3.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic and its effects on an individual's life have altered the consumer behavior. In the context of purchase and consumption, a shift from conventional to green purchase has been noticed. Although the factors underlying this shift were relatively unexplored, the study aimed to identify the factors that influenced a significant role in the green purchases during the outbreak and the relationship of these factors with green purchase behavior (GPB). Subsequently, this study investigates and interprets the role of fear of COVID-19 (FCV), psychological distress (PD), and mortality salience (MS) in predicting consumer's GPB. This research adopted a quantitative methodology using data collected from 432 respondents in various cities across Pakistan. Smart-PLS 3 was used to evaluate the measurement model, structural model, and multi-group analysis (MGA). Despite having the negative psychological and physical impact of the pandemic, a significant proportion of customers have switched to healthier and sustainable products. This research revealed that the FCV, PD, and MS plays a substantial role in adopting GPB. All the direct relationships were positive and significant. In addition, MS and PD partially mediate the effect of FCV on GPB. Furthermore, the MGA revealed that the infected respondents were interested in purchasing green products than uninfected respondents due to their FCV; conversely, the PD and MS were higher in uninfected individuals than infected ones. However, there is a vast literature on GPB, but little has investigated the cumulative impact of FCV, PD, and MS on GPB.Entities:
Keywords: COVID-19; fear of COVID-19; green purchase behavior; mortality salience; psychological distress
Year: 2022 PMID: 35422735 PMCID: PMC9002235 DOI: 10.3389/fpsyg.2022.826870
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Conceptual model.
Demographic profile.
| Characteristics | Frequency | % |
|
| ||
| Female | 249 | 57.7 |
| Male | 183 | 42.3 |
|
| ||
| Below 20 | 35 | 8.3 |
| 20–29 | 248 | 57.6 |
| 30–39 | 114 | 26.4 |
| 40–49 and above | 35 | 8.3 |
|
| ||
| Employed full-time | 174 | 39.6 |
| Employed part-time | 86 | 20.1 |
| Unemployed | 172 | 40 |
|
| ||
| Less than Rs.25,000 | 38 | 9 |
| Rs25,000–50,000 | 101 | 23.6 |
| Rs50,000–100,000 | 80 | 18 |
| Rs10,000–150,000 | 75 | 17.4 |
| Rs150,000–200,000 | 138 | 32 |
|
| ||
| Infected | 172 | 39.8 |
| Uninfected | 260 | 60.2 |
Measures and their sources.
| Measures | Items | Source |
| Green purchase behavior | 7 items |
|
| Fear of COVID-19 | 7 items |
|
| Psychological distress | 14 items |
|
| Mortality salience | 15 items |
|
Items, Cronbach’s α, standard loading, composite reliability, and average variance extracted (AVE).
| Constructs | Items | Standardized loading | Cronbach’s alpha | CR | AVE | |
|
| 0.914 | 0.932 | 0.662 | |||
| FCV-1 | I am most afraid of coronavirus-19. | 0.802 | ||||
| FCV-2 | It makes me uncomfortable to think about coronavirus-19. | 0.751 | ||||
| FCV-3 | My hands become clammy when I think about coronavirus-19. | 0.87 | ||||
| FCV-4 | I am afraid of losing my life because of coronavirus-19. | 0.826 | ||||
| FCV-5 | When watching news and stories about coronavirus-19 on social media, I become nervous or anxious. | 0.73 | ||||
| FCV-6 | I cannot sleep because I’m worrying about getting coronavirus-19. | 0.852 | ||||
| FCV-7 | My heart races or palpitates when I think about getting coronavirus-19. | 0.854 | ||||
|
| 0.928 | 0.942 | 0.699 | |||
| MS-1 | When it comes to COVID-19, I am very much afraid to die | 0.823 | ||||
| MS-2 | When it comes to COVID-19, the thought of death often hits my mind | 0.831 | ||||
| MS-3 | I feel nervous when thinking of the death scene caused by COVID-19 | 0.787 | ||||
| MS-4 | I feel terrified if I got quarantined and medical treatment because of COVID-19 infection | 0.777 | ||||
| MS-5 | I am scared of COVID-19 infection | 0.839 | ||||
| MS-6 | I am terrified of death caused by COVID-19 | 0.841 | ||||
| MS-7 | When it comes to COVID-19, The thought of death never bothers me. | 0.828 | ||||
| MS-8 | When it comes to COVID-19, I constantly feel that time flies and time is short | 0.852 | ||||
| MS-9 | When it comes to COVID-19, I fear dying a painful death | 0.824 | ||||
| MS-10 | The topic of COVID-19 death makes me feel worried and resignation | 0.862 | ||||
| MS-11 | I was afraid I do not have enough immunity to resist the Coronavirus effectively | 0.835 | ||||
| MS-12 | When it comes to COVID-19, I often think of how fragile life is | 0.791 | ||||
| MS-13 | I shudder at the thought of the heavy casualties of the COVID-19 | 0.837 | ||||
| MS-14 | I feel scared and sad when I saw the news about the numbers of deaths caused by the COVID-19 | 0.7 | ||||
| MS-15 | When it comes to COVID-19, I’m worried about the future | 0.676 | ||||
|
| 0.962 | 0.965 | 0.654 | |||
| PD-1 | If I was infected with COVID-19, I might not be able to recover from it. | 0.796 | ||||
| PD-2 | When talking to a stranger, I would suspect that s/he might be infected with COVID-19. | 0.814 | ||||
| PD-3 | I am afraid to travel to places hard-hit by COVID-19. | 0.792 | ||||
| PD-4 | When I see an increase in the number of COVID-19 patients on the news, I feel anxious. | 0.801 | ||||
| PD-5 | When I see someone sneeze, I suspect s/he might be infected with COVID-19. | 0.838 | ||||
| PD-6 | I think frequent hospital visits would make it easier to be infected with COVID19. | 0.842 | ||||
| PD-7 | I fear to see the doctors and nurses who had worked in COVID-19 isolation wards. | 0.826 | ||||
| PD-8 | I think frequent use of air, train, bus and other public transport would make it easier to be infected with COVID-19. | 0.86 | ||||
| PD-9 | When I notice someone running a fever, I suspect s/he might be infected with COVID-19. | 0.875 | ||||
| PD-10 | When I see someone vomiting, I suspect s/he might be infected with COVID-19. | 0.789 | ||||
| PD-11 | I fear to live nearby a COVID-19 isolation hospital. | 0.816 | ||||
| PD-12 | When I see someone coughing, I suspect s/he might be infected with COVID-19. | 0.872 | ||||
| PD-13 | When I see someone without a mask, I suspect s/he might be infected with COVID-19. | 0.759 | ||||
| PD-14 | I suspect there were novel coronavirus in the air when there were people around. | 0.816 | ||||
|
| 0.963 | 0.966 | 0.675 | |||
| GPB-1 | I often buy organic products. | 0.775 | ||||
| GPB-2 | I often buy products that are labeled as environmentally safe. | 0.886 | ||||
| GPB-3 | I often buy products that are against animal-testing | 0.848 | ||||
| GPB-4 | I often buy products that contain no or fewer chemical ingredients | 0.824 | ||||
| GPB-5 | When I consider buying a product, I will look for a certified environmentally safe or organic stamp. | 0.887 | ||||
| GPB-6 | I often buy products that support fair community trades. | 0.872 | ||||
| GPB-7 | I often buy products that use recycled/recyclable packaging. | 0.749 | ||||
AVE (Average Variance Extracted), CR (Composite Reliability).
Discriminant validity—Fornell–Larcker criterion.
| Constructs | FCV | GPB | MS | PD |
| FCV |
| |||
| GPB | 0.501 |
| ||
| MS | 0.609 | 0.543 |
| |
| PD | 0.613 | 0.577 | 0.800 |
|
Diagonal (italic) values are the square root of the AVE values of each respective construct.
Discriminant validity—Heterotait-Monotrait (HTMT) ratio.
| Sr. no | Constructs | HTMT correlations | |||
| 1 | 2 | 3 | 4 | ||
| 1 | Fear of covid-19 | ||||
| 2 | Green purchase behavior | 0.539 | |||
| 3 | Mortality salience | 0.638 | 0.571 | ||
| 4 | Psychological distress | 0.637 | 0.592 | 0.831 | _ |
The criterion for HTMT ratio is below 0.90.
FIGURE 2The bootstrapping result.
Structural relationship and hypothesis testing.
| Hypothesis | Path | Path coefficient | T statistics | Decision | |
| H1 | FCV -> GPB | 0.503 | 11.105 | 0 | Supported |
| H2 | FCV -> PD | 0.613 | 17.084 | 0 | Supported |
| H3 | FCV -> MS | 0.61 | 15.627 | 0 | Supported |
| H4 | PD -> GPB | 0.381 | 3.898 | 0 | Supported |
| H5 | MS -> GPB | 0.238 | 2.476 | 0.014 | Supported |
p < 0.05.
Mediation analysis.
| Path | Indirect effect | Total effect | VAF (indirect effect/total effect) | Type of mediation |
| FCV -> MS -> GPB | 0.229 | 0.502 | 0.4561 = 45.61% | Partial |
| FCV -> PD -> GPB | 0.259 | 0.502 | 0.5159 = 51.59% | Partial |
VAF, Variance Accounted for.
Multi-group analysis.
| Path | Path coefficients-diff (infected—uninfected) | |
| FCV -> GPB |
|
|
| FCV -> MS |
|
|
| FCV -> PD |
|
|
| MS -> GPB | 0.149 | 0.420 |
| PD -> GPB | –0.343 | 0.053 |
The italic values show the significant difference.